Underutilization of medications to treat opioid use disorder: What role does stigma play?

Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?

(2019) Molly Doernberg et al.   Substance Abuse

Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality

(2018) Marc R. Larochelle et al.   ANNALS OF INTERNAL MEDICINE

Management of opioid use disorders: a national clinical practice guideline

(2018) Julie Bruneau et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Public Health Detailing for HIV Pre-Exposure Prophylaxis

(2018) Kevin L Ard et al.   CLINICAL INFECTIOUS DISEASES

Do Words Matter? Stigmatizing Language and the Transmission of Bias in the Medical Record

(2018) Anna P. Goddu et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

(2018) Joshua D Lee et al.   LANCET

Moving Addiction Care to the Mainstream — Improving the Quality of Buprenorphine Treatment

(2018) Brendan Saloner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tackling racism as a “wicked” public health problem: Enabling allies in anti-racism praxis

(2018) Heather Came et al.   SOCIAL SCIENCE & MEDICINE

A decade of studying implicit racial/ethnic bias in healthcare providers using the implicit association test

(2018) Ivy W. Maina et al.   SOCIAL SCIENCE & MEDICINE

National trends and characteristics of inpatient detoxification for drug use disorders in the United States

(2018) He Zhu et al.   BMC PUBLIC HEALTH

Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis

(2018) Jack Stone et al.   LANCET INFECTIOUS DISEASES

Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine

(2017) Noa Krawczyk et al.   HEALTH AFFAIRS

Medications For Addiction Treatment

(2017) Sarah E. Wakeman   Journal of Addiction Medicine

Stigma and Self-Stigma in Addiction

(2017) Steve Matthews et al.   Journal of Bioethical Inquiry

Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states

(2017) Traci C. Green et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Structural racism and health inequities in the USA: evidence and interventions

(2017) Zinzi D Bailey et al.   LANCET

Public Health Detailing to Increase Routine HIV Screening in Baltimore, Maryland: Satisfaction, Feasibility, and Effectiveness

(2017) Amelia Greiner Safi et al.   PUBLIC HEALTH REPORTS

Barriers to Medications for Addiction Treatment: How Stigma Kills

(2017) Sarah E. Wakeman et al.   SUBSTANCE USE & MISUSE

At the Expense of a Life: Race, Class, and the Meaning of Buprenorphine in Pharmaceuticalized “Care”

(2017) Alexandrea E. Hatcher et al.   SUBSTANCE USE & MISUSE

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

(2017) Luis Sordo et al.   BMJ-British Medical Journal

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

(2017) Luis Sordo et al.   BMJ-British Medical Journal

Primary care physicians’ perspectives on the prescription opioid epidemic

(2016) Alene Kennedy-Hendricks et al.   DRUG AND ALCOHOL DEPENDENCE

Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations

(2016) Laramie R. Smith et al.   DRUG AND ALCOHOL DEPENDENCE

Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City

(2016) Helena Hansen et al.   DRUG AND ALCOHOL DEPENDENCE

“I'm Going to Shut Down All of Your Tricks”: Depictions of Treatment Professionals in Addiction Entertainment

(2016) Kimberly M. Baker   SUBSTANCE USE & MISUSE

Attitudes, practices, and preparedness to care for patients with substance use disorder: Results from a survey of general internists

(2016) Sarah E. Wakeman et al.   Substance Abuse

Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014

(2016) Rose A. Rudd et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Stop Talking ‘Dirty’: Clinicians, Language, and Quality of Care for the Leading Cause of Preventable Death in the United States

(2015) John F. Kelly et al.   AMERICAN JOURNAL OF MEDICINE

National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment

(2015) Christopher M. Jones et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Black Lives Matter: A Commentary on Racism and Public Health

(2015) Jennifer Jee-Lyn García et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002–11

(2015) Andrew W. Dick et al.   HEALTH AFFAIRS

Systemic racism and U.S. health care

(2014) Joe Feagin et al.   SOCIAL SCIENCE & MEDICINE

Language and Addiction: Choosing Words Wisely

(2013) Sarah E. Wakeman   AMERICAN JOURNAL OF PUBLIC HEALTH

A Collaborative Approach to Teaching Medical Students How to Screen, Intervene, and Treat Substance Use Disorders

(2012) Karin J. Neufeld et al.   Substance Abuse

Standardized measures for substance use stigma

(2011) Seth A. Brown   DRUG AND ALCOHOL DEPENDENCE

Stigma and Addiction: Being and Becoming

(2009) Daniel Buchman et al.   AMERICAN JOURNAL OF BIOETHICS

Exposure to opioid maintenance treatment reduces long-term mortality

(2008) Amy Gibson et al.   ADDICTION